1
Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder
Condition(s):Urinary Bladder CancerLast Updated:April 2, 2020Recruiting
Urothelial Carcinoma of the Bladder: 485 Clinical Trials, Page 1 of 49
Hide Studies Not Open or Pending
2
Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder
Condition(s):Urothelial Carcinoma of the Urinary BladderLast Updated:June 28, 2018Active, not recruiting
3
BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
Condition(s):Bladder Cancer; Non-Muscle-Invasive Urothelial CarcinomaLast Updated:February 5, 2020Active, not recruiting
4
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
Condition(s):Bladder Cancer, BiomarkersLast Updated:August 13, 2018Completed
5
Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder
Condition(s):Urothelial CarcinomaLast Updated:April 15, 2020Active, not recruiting
6
ADAPT-BLADDER: Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder
Condition(s):Urothelial Carcinoma; Bladder CancerLast Updated:April 17, 2020Recruiting
7
Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging
Condition(s):Muscle-invasive Bladder CancerLast Updated:September 4, 2020Recruiting
8
Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder
Condition(s):Urothelial Carcinoma; Bladder CancerLast Updated:September 11, 2020Recruiting
9
A Study of TAR-200 in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who Are Unfit for Radical Cystectomy
Condition(s):Urinary Bladder NeoplasmsLast Updated:September 24, 2020Active, not recruiting
10
Avelumab and Radiation in Muscle-Invasive Bladder Cancer
Condition(s):Bladder Cancer; Muscle Invasive Bladder CancerLast Updated:April 8, 2020Recruiting